시장보고서
상품코드
1299773

인간 초대 세포 시장 : 제품 유형, 분리, 세포 유형, 용도, 국가 및 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Human Primary Cells Market with COVID-19 Impact Analysis, By Product Type, By Separation, By Cell Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 323 Pages | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서의 하이라이트

인간 초대 세포 시장 규모는 2022년 13억 6,070만 달러로 2023년부터 2030년까지 11.5%의 CAGR로 확대

인간 초대 세포 시장 - 시장 역학:

초대 세포 시장의 성장 배경에는 노인 인구의 증가, 연구 개발의 발전, 만성 질환 환자의 증가가 있습니다. 또한, 의약품 시장은 첨단 검사 및 의약품 개발로 크게 성장하고 있습니다. 이에 따라 인간 초대 세포 시장의 채택이 증가할 것으로 예상됩니다. 그러나 원자재 가용성 제한과 고가의 공정은 예측 기간 동안 시장 성장을 저해하는 주요 요인으로 작용할 것으로 보입니다.

또한, 일차 세포 배양은 신약의 세포 독성을 확인하기 위해 사용됩니다. 또한, 인간 초대 세포는 화학제품, 화장품 및 신약의 효과를 테스트하기 위해 동물 모델 대신에 사용됩니다. COVID-19 팬데믹은 인간 초대 세포 시장에 긍정적인 영향을 미치고 있으며, 이는 시장 성장을 촉진할 것으로 예상되는 주요 요인입니다. 인간 초대 세포는 연구자들이 감염병을 이해하기 위해 사용합니다. 특성화되고 표준화된 상피세포 배양 모델은 코로나바이러스가 파괴한 물리적 장벽을 이해하는 데 도움이 되고 있습니다. 이 모델은 호흡기의 특성과 기능을 모방하는 데 도움이 되며, 연구 결과를 의료 응용으로 전환할 수 있는 돌파구가 될 수 있습니다.

인간 초대 세포 시장 - 세분화 분석:

세계 인간 초대 세포 시장은 제품 유형, 분리, 세포 유형, 용도 및 지역에 따라 세분화됩니다.

제품 유형에 따라 시장은 인간 초대 세포, 시약 및 보충제, 배지 등 세 가지로 분류됩니다. 시약 및 보충제 분야가 시장을 점유할 것으로 예상됩니다. 인간 초대 세포는 시약 및 보충제의 제조 및 연구에서 일상적인 응용에 관여합니다. 시약과 보충제는 인간 초대 세포가 성장하기 위해 깨지기 쉽기 때문에 매우 중요한 것으로 간주됩니다.

시장은 분리를 기준으로 추출법, 효소 분해법, 기계적 분리법 및 기타로 나뉩니다. 효소 분해 방법은 예측 기간 동안 우위를 유지할 것으로 보입니다. 이는 인간 초대 세포의 분리에서 효소 분해법이 다른 기술을 대체하여 비교적 빠르고, 대표 시료의 수율이 높고, 배양물에 대한 손상이 적다는 장점으로 인해 효소 분해법이 높은 평가를 받고 있기 때문입니다.

시장은 세포 유형에 따라 동물용과 인체용으로 나뉩니다. 동물 분야가 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 백신 개발을 위해 동물 유래 인간 초대 세포의 사용이 증가하고 있는 것이 이 분야의 성장을 촉진하는 중요한 요인으로 작용하고 있습니다.

용도별로는 조직배양 및 조직공학, 백신 생산, 유전자 치료 및 재생의료, 독성시험 및 약물 스크리닝, 바이러스학, 암 연구, 줄기세포 치료, 모델 시스템, 산전진단 및 기타 9가지 카테고리로 분류됩니다. 예측 기간 동안 백신 생산 분야가 시장을 주도할 것으로 예상되며, B형 간염, 홍역 등 다양한 백신 생산에 사용되는 바이러스를 생산하기 위해 동물 초대 배양을 활용하는 사례가 증가하고 있습니다.

인간 초대 세포 시장 - 경쟁 상황:

인간 초대 세포 시장은 다양한 면역 결핍 질환의 치료에 인간 초대 세포를 활용하여 더 나은 치료법을 개발하기 위한 연구개발 활동에 대한 활발한 투자로 인해 전 세계적으로 빠르게 성장하고 있습니다. 또한, 바이오의약품 및 생명공학 분야의 성장과 함께 의학 연구자들은 악성 암 치료를 위해 인간 및 동물 조직에서 채취한 인간 초대 세포를 사용하는 연구를 계속하고 있습니다. 또한 주요 기업들은 시장 수익을 높이기 위해 신제품 출시, M&A, R&D 비용, 파트너십, 제휴 등의 전략을 채택하고 있습니다. 예를 들어, 2021년 8월 Axol Bioscience Ltd는 CENSO Biotechnologies와의 합병을 발표했습니다. 합병 후의 사업체는 서비스 솔루션 및 제품 분야의 선도적인 공급업체가 될 것입니다. 또한, 검증된 즉시 사용 가능한 세포주, 강력한 기능 데이터, 맞춤형 기능 및 광범위한 전문 지식을 갖춘 일련의 서비스를 고객에게 빠른 리드 타임으로 제공하게 될 것입니다.

연구의 주요 특징

인간 초대 세포 시장에 대한 이 조사 보고서는 2022년을 기준 연도로 하여 시장 규모, 연평균 성장률(CAGR %), 추정 및 예측(2023-2030년)을 제공합니다.

이 조사 보고서는 다양한 부문/국가에 걸쳐 잠재적인 성장 기회를 파악하고 인간 초대 세포 시장의 매력적인 투자 제안 매트릭스를 설명합니다.

이 보고서는 전체 보고서에서 신규 투자 기회, 기존 기업이 직면한 과제, 인간 초대 세포 시장에서 지속가능한 성장 요인을 확인했습니다.

COVID-19가 인간 초대 세포 시장 규모, 예측, CAGR 및 시장 역학에 미치는 영향에 대해 연구 범위에서 자세히 논의하고, 코로나 이후 인간 초대 세포 시장에 대한 심층적인 인사이트도 다루고 있습니다.

이 보고서는 사용자에게 인간 초대 세포 시장에 대한 종합적인 관점을 제공하기 위해 인간 초대 세포 시장의 경쟁 상황과 주요 혁신가 분석도 포함하고 있습니다.

이 보고서는 시장 규모, 성장률, 매력도를 기준으로 모든 산업 부문을 벤치마킹하는 성장 전망 매핑 분석을 다루고 있습니다.

이 보고서는 주요 시장 참여업체들의 상세한 기업 개요를 제공하여 인간 초대 세포 시장에서 활동하는 기업들의 재무 정보 및 전략적 이니셔티브를 이해하는 데 도움이 될 것입니다.

또한, 이 보고서는 세계뿐만 아니라 지역적 차원에서 시장에 참여하는 주요 기업들의 주요 인수합병, 제휴 및 합작투자, 신제품 출시, 연구개발, 지역적 진출에 대해서도 설명합니다.

인간 초대 세포 세계 시장 보고서는 주로 공급 업체, 투자자, 신규 진입자, 유통 업체, 금융 분석가 등 이 산업의 다양한 이해 관계자를 대상으로 합니다.

목차

제1장 인간 초대 세포 시장 개요

  • 조사 범위

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 인간 초대 세포 주요 시장 동향

  • 인간 초대 세포 시장 성장 촉진요인
  • 인간 초대 세포 시장 성장 억제요인
  • 인간 초대 세포 시장 기회
  • 인간 초대 세포 시장 향후 동향

제4장 인간 초대 세포 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 체계 분석

제5장 인간 초대 세포 시장 : COVID-19의 영향 분석

  • 신종 코로나바이러스 감염증 이전의 영향 분석
  • 신종 코로나바이러스 감염증 이후의 영향 분석

제6장 인간 초대 세포 시장 상황

  • 인간 초대 세포 시장 점유율 분석, 2022년
  • 주요 제조업체별 내역 데이터
    • 확립된 기업 분석
    • 신흥 기업 분석

제7장 인간 초대 세포 시장 - 제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 인간 초대 세포
    • 시약과 보충제
    • 미디어

제8장 인간 초대 세포 시장 - 분리별

  • 개요
    • 부문별 부문 점유율 분석
    • 외식법
    • 효소 분해
    • 기계적 분리
    • 기타

제9장 인간 초대 세포 시장 - 세포 유형별

  • 개요
    • 셀 유형별 부문 점유율 분석
    • 동물
    • 인간

제10장 인간 초대 세포 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 조직배양과 조직공학
    • 백신 생산
    • 유전자 치료와 재생의료
    • 독성 시험과 약물 스크리닝
    • 암 조사
    • 줄기세포 치료
    • 모델 시스템
    • 산전 진단
    • 기타

제11장 인간 초대 세포 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 인간 초대 세포 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 인간 초대 세포 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 인간 초대 세포 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 인간 초대 세포 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 인간 초대 세포 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 인간 초대 세포 산업

  • 경쟁 대시보드
  • 기업 개요
    • Merck Group
    • ATCC
    • Thermo Fisher Scientific Inc
    • Sigma-Aldrich Co.
    • Charles River Laboratories
    • Merck Group
    • Axol Bioscience
    • ReachBio Research Labs
    • STEMCELL Technologies Inc
    • Lonza
    • Cell Biologics, Inc.
    • PromoCell-Human Centered Science
    • ZenBio, Inc.
    • AllCells

제13장 애널리스트의 전방위적 전망

ksm 23.08.17

REPORT HIGHLIGHT

Human Primary Cells market size was valued at USD 1,360.7 Million in 2022, expanding at a CAGR of 11.5% from 2023 to 2030.

Human Primary Cells are also known as mature cells extracted from living tissues of humans and animals after that processed to establish them for utilization in appropriate cell therapies. Additionally, Human Primary Cells are also used in several applications such as cancer research, 3D cell culture, tissue replacement, stem cell therapy, and virology. 3D cell culture is increasingly used by researchers to study cell biology and biochemistry, cell-pathogen interactions, drug effects, and cell signaling.

Human Primary Cells Market- Market Dynamics:

The primary cell market growth is attributed to the increasing geriatric population, advancements in development and research, and a rise in cases of chronic diseases. Additionally pharmaceutical market is growing significantly in advanced testing and drug development. This in turn projected to facilitate increased adoption of the Human Primary Cells market. However, restrictions implemented for the utilization of raw materials and expensive processes are the major factors hindering the market growth during the forecast period.

Moreover, primary cell cultures are used to identify the cytotoxicity of new drugs. Furthermore, Human Primary Cells are used in the place of animal models to test the effects of chemicals, cosmetics, and new drugs. These are some major factors expected to drive market growth. The COVID-19 pandemic has impacted the Human Primary Cells market positively. Human Primary Cells are used by researchers for understanding the infection. Characterized and standardized epithelium cell culture models are helping to understand the physical barrier devastated by the coronavirus. The models can assist mimic the properties and functions of the respiratory tract which leads to a breakthrough for a research outcome moving into a medical application

Human Primary Cells Market- Segmentation Analysis:

The global Human Primary Cells market is segmented on the basis of product type, separation, cell type, application, and region.

The market is divided into three categories based on product type: Human Primary Cells, reagents and supplements, and media. The reagents and supplements sector is expected to possess the market. Human Primary Cells are involved in reagents and supplements' routine application in manufacturing and research. The reagents and supplements are considered very crucial as Human Primary Cells are fragile for their growth.

The market is divided into three categories based on separation: explant method, enzymatic degradation, mechanical separation, and others. The enzymatic degradation sector is likely to maintain its dominance during the forecast period. This is partly due to its high preference at the place of other techniques for the separation of Human Primary Cells owing to its advantages such as comparatively fast, high yield of a representative sample, and less damage to cultures.

The market is divided into two categories based on cell type: animal and human. The animal sector is expected to hold the largest market share. For vaccine development, increasing the application of animal-origin Human Primary Cells are essential factor propelling the segment growth.

The market is divided into nine categories based on application: tissue culture & tissue engineering, vaccine production, gene therapy and regenerative medicine, toxicity testing & drug screening, virology, cancer research, stem cell therapy, model system, prenatal diagnosis, and others. The vaccine production sector is expected to dominate the market over the forecast period. Rising use of primary animal culture for the production of virus that is later utilized for producing various vaccines including hepatitis B and measles.

Human Primary Cells Market-Competitive Landscape:

The Human Primary Cells market is rapidly driven globally by robust investment in research and development activities for the increment of better therapies where Human Primary Cells can be utilized to treat various immunodeficiency disorders. Additionally, with The growth in biopharmaceutical and biotechnology sectors, medical researchers are continuously working on using Human Primary Cells from human and animal tissues for the treatment of malignant cancers. Moreover, key players are adopting strategies such as new product launches, mergers & acquisitions, R&D spending, partnerships, and collaboration to enhance their market revenue. For instance, in August 2021, Axol Bioscience Ltd announced its merger with CENSO Biotechnologies. The merged entity will become a leading provider of service solutions and products. Additionally, it will provide customers with validated ready-to-use cell lines and a suite of services with robust functional data, customization capabilities, and broader expertise, all with shorter lead times.

Key features of the study:

This proposed research study on Human Primary Cells market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Human Primary Cells market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Human Primary Cells market.

Impact of COVID-19 on Human Primary Cells market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Human Primary Cells market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Human Primary Cells market, we have also included competitive landscape and key innovator analysis for Human Primary Cells market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the Human Primary Cells market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global Human Primary Cells market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN PRIMARY CELLS MARKET KEY PLAYERS

  • Merck Group
  • ATCC
  • Thermo Fisher Scientific Inc
  • Sigma-Aldrich Co.
  • Charles River Laboratories
  • Merck Group
  • Axol Bioscience
  • ReachBio Research Labs
  • STEMCELL Technologies Inc
  • Lonza
  • Cell Biologics, Inc.
  • PromoCell - Human Centered Science
  • ZenBio, Inc.
  • AllCells

GLOBAL HUMAN PRIMARY CELLS MARKET, BY PRODUCT TYPE

  • Human Primary Cells
  • Reagents and Supplements
  • Media

GLOBAL HUMAN PRIMARY CELLS MARKET, BY SEPARATION

  • Explant Method
  • Enzymatic Degradation
  • Mechanical Separation
  • Others

GLOBAL HUMAN PRIMARY CELLS MARKET, BY CELL TYPE

  • Animal
  • Human

GLOBAL HUMAN PRIMARY CELLS MARKET, BY APPLICATION

  • Tissue Culture & Tissue Engineering
  • Vaccine Production
  • Gene Therapy and Regenerative Medicine
  • Toxicity Testing and Drug Screening
  • Cancer Research
  • Stem Cell Therapy
  • Model System
  • Prenatal Diagnosis
  • Others

GLOBAL HUMAN PRIMARY CELLS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Human Primary Cells Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Human Primary Cells Market Snippet by Product Type
    • 2.1.2. Human Primary Cells Market Snippet by Separation
    • 2.1.3. Human Primary Cells Market Snippet by Cell Type
    • 2.1.4. Human Primary Cells Market Snippet by Application
    • 2.1.5. Human Primary Cells Market Snippet by Country
    • 2.1.6. Human Primary Cells Market Snippet by Region
  • 2.2. Competitive Insights

3. Human Primary Cells Key Market Trends

  • 3.1. Human Primary Cells Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Human Primary Cells Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Human Primary Cells Market Opportunities
  • 3.4. Human Primary Cells Market Future Trends

4. Human Primary Cells Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Human Primary Cells Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Human Primary Cells Market Landscape

  • 6.1. Human Primary Cells Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Human Primary Cells Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
    • 7.1.2. Human Primary Cells
    • 7.1.3. Reagents and Supplements
    • 7.1.4. Media

8. Human Primary Cells Market - By Separation

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Separation, 2022&2030 (%)
    • 8.1.2. Explant Method
    • 8.1.3. Enzymatic Degradation
    • 8.1.4. Mechanical Separation
    • 8.1.5. Others

9. Human Primary Cells Market - By Cell Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Cell Type, 2022&2030 (%)
    • 9.1.2. Animal
    • 9.1.3. Human

10. Human Primary Cells Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 10.1.2. Tissue Culture & Tissue Engineering
    • 10.1.3. Vaccine Production
    • 10.1.4. Gene Therapy and Regenerative Medicine
    • 10.1.5. Toxicity Testing and Drug Screening
    • 10.1.6. Cancer Research
    • 10.1.7. Stem Cell Therapy
    • 10.1.8. Model System
    • 10.1.9. Prenatal Diagnosis
    • 10.1.10. Others

11. Human Primary Cells Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Human Primary Cells Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Human Primary Cells Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Human Primary Cells Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Human Primary Cells Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Human Primary Cells Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Human Primary Cells Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Merck Group
    • 12.2.2. ATCC
    • 12.2.3. Thermo Fisher Scientific Inc
    • 12.2.4. Sigma-Aldrich Co.
    • 12.2.5. Charles River Laboratories
    • 12.2.6. Merck Group
    • 12.2.7. Axol Bioscience
    • 12.2.8. ReachBio Research Labs
    • 12.2.9. STEMCELL Technologies Inc
    • 12.2.10. Lonza
    • 12.2.11. Cell Biologics, Inc.
    • 12.2.12. PromoCell - Human Centered Science
    • 12.2.13. ZenBio, Inc.
    • 12.2.14. AllCells

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제